Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025 Jul 31, 2025 08:10 HKT/SGT Read More
Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence Jul 29, 2025 16:00 HKT/SGT Read More
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma Jul 29, 2025 08:01 HKT/SGT Read More
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China Jul 29, 2025 05:00 JST Read More
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China Jul 29, 2025 04:00 HKT/SGT Read More
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China Jul 25, 2025 11:52 JST Read More
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million Jul 25, 2025 11:01 JST Read More
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China Jul 25, 2025 10:52 HKT/SGT Read More
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million Jul 25, 2025 10:01 HKT/SGT Read More
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration Jul 24, 2025 09:00 HKT/SGT Read More